New Delhi, Dec. 8 -- With Zerodha co-founder Nikhil Kamath having already hosted tech billionaire Elon Musk on his WTF is podcast, the question on everyone's mind is: who's the next guest? While many... Read More
India, Dec. 8 -- Choosing sofa sets for a drawing room feels far easier when you know what truly works for busy homes. The best way to figure out the right match is to understand how people move throu... Read More
New Delhi, Dec. 8 -- The Indian stock market witnessed broad-based selling during Monday's session, December 8, a day after the RBI trimmed the key benchmark rate by another 25 basis points. Although ... Read More
Shimla, Dec. 8 -- In a fresh twist to the ongoing Sanjauli mosque dispute in Shimla, the All Himachal Muslims Organisation on Monday presented an old revenue record from 1915, claiming that the mosque... Read More
India, Dec. 8 -- The Enforcement Directorate (ED) has filed 6,444 money laundering cases, 2,416 charge sheets against 16,404 individuals and entities, and carried out 11,106 searches since 2014, when ... Read More
New Delhi, Dec. 8 -- The Indian stock market ended with deep cuts on Monday, December 8, as investors sold stocks across segments amid mixed global cues. The Sensex closed 610 points, or 0.71%, lower ... Read More
New Delhi, Dec. 8 -- The Indian stock market ended with deep cuts on Monday, December 8, as investors sold stocks across segments amid mixed global cues. The Sensex closed 610 points, or 0.71%, lower ... Read More
New Delhi, Dec. 8 -- The International Monetary Fund (IMF) report on 'Growing Retail Digital Payments (The Value of Interoperability)' dated June 2025 had recognized Unified Payments Interface (UPI) a... Read More
Mumbai, Dec. 8 -- According to the company's exchange filing, the supply contract will be executed over a five-year period, from December 2025 to 2030. The company also clarified that neither its prom... Read More
Mumbai, Dec. 8 -- Eftilagimod alfa is a novel immunotherapy with the potential to set a new standard of care in combination with anti-PD- (L)1 and chemotherapy as first-line therapy for non-small cell... Read More